A Comparison of Streptococcus pyogenes (Group A Streptococcal) Bacteremia at an Urban and a Suburban Hospital
- 13 December 1993
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of internal medicine (1960)
- Vol. 153 (23) , 2679-2684
- https://doi.org/10.1001/archinte.1993.00410230097011
Abstract
Background: There has been a recent resurgence of severe infections withStreptococcus pyogenes, including bacteremias and a toxic shock—like syndrome. The purpose of this study was to examine the influence of intravenous drug use on the incidence, clinical epidemiology, and severity ofS pyogenesbacteremia. Methods: We conducted a retrospective survey of medical records at a 500-bed tertiary care urban hospital and at a nearby 500-bed suburban university-affiliated hospital. All patients from each hospital with documentedS pyogenesbacteremia from January 1, 1979, to December 31, 1989, were included. We examined demographic and clinical data from cases at the two institutions, serologic findings from a subset of isolates from the urban hospital, and factors associated with mortality fromS pyogenesbacteremia by stepwise logistic regression analysis. Results: Ninety-five cases ofS pyogenesbacteremia were identified, with 65% (62 cases) occurring at the urban center. Intravenous drug use occurred more frequently at the urban center (P<.005); the injecting drug users were significantly younger than the non—drug-using population (P=.001). Infection with the human immunodeficiency virus occurred in a subset of the injecting drug users at the urban center. Cellulitis and cutaneous abscesses were the most common sources of bacteremia at both centers. During the study period, the numbers ofS pyogenesbacteremias increased at the urban center (P=.007), accompanied by a significant increase in the proportion of infections associated with parenteral drug use (P=.003). There was no change in the prevalence of any T type throughout the study period and no clustering of T types among injecting drug users. The overall mortality was 23% (20/89). By logistic regression analysis, age older than 65 years (relative risk [RR], 14; 95% confidence interval [CI], 3.2 to 68) and the presence of the toxic shock— like syndrome (RR, 36; 95% CI, 2.2 to 600) were significantly associated with mortality due toS pyogenesbacteremia. Conclusions: Intravenous drug use accounted for an increase in cases ofS pyogenesbacteremia at an innercity hospital. However, advanced age and the toxic shock—like syndrome were the most important predictors of mortality. (Arch Intern Med. 1993;153:2679-2684)This publication has 16 references indexed in Scilit:
- Outbreak of Group A Streptococcal Bacteremia in Sweden: An Epidemiologic and Clinical StudyThe Journal of Infectious Diseases, 1991
- Varied Presentations of Sporadic Group A Streptococcal Bacteremia: Clinical Experience and Attempt at ClassificationClinical Infectious Diseases, 1990
- Characteristics of Group A Streptococcal Bacteremia in Patients at the San Bernardino County Medical CenterClinical Infectious Diseases, 1990
- Group A Streptococcal Infections and a Toxic Shock–like SyndromeNew England Journal of Medicine, 1989
- Group A Streptococcal Serotypes Isolated from Patients and Sibling Contacts During the Resurgence of Rheumatic Fever in the United States in the Mid-1980sThe Journal of Infectious Diseases, 1989
- 'Toxic strep syndrome'. A manifestation of group A streptococcal infectionArchives of internal medicine (1960), 1988
- Changing group A streptococci. The reappearance of streptococcal 'toxic shock'Archives of internal medicine (1960), 1988
- Streptococcus pyogenes and the Toxic Shock SyndromeAnnals of Internal Medicine, 1988
- Clinical and Bacteriologic Observations of a Toxic Shock–like Syndrome Due toStreptococcus pyogenesNew England Journal of Medicine, 1987
- Group A streptococcal bacteremia in intravenous drug abusersThe American Journal of Medicine, 1985